Literature DB >> 14664754

Is it time for oncologists to modify their laissez-faire attitude toward alternative/complementary 'drug therapy'?

Maurie Markman.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 14664754     DOI: 10.1007/s11912-996-0001-0

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  19 in total

1.  Acute heart transplant rejection due to Saint John's wort.

Authors:  F Ruschitzka; P J Meier; M Turina; T F Lüscher; G Noll
Journal:  Lancet       Date:  2000-02-12       Impact factor: 79.321

2.  Urothelial malignant disease and Chinese herbal nephropathy.

Authors:  G M Lord; T Cook; V M Arlt; H H Schmeiser; G Williams; C D Pusey
Journal:  Lancet       Date:  2001-11-03       Impact factor: 79.321

3.  PC-SPES--a lesson for future dietary supplement research.

Authors:  Jeffrey White
Journal:  J Natl Cancer Inst       Date:  2002-09-04       Impact factor: 13.506

4.  Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse.

Authors:  C V Fernandez; C A Stutzer; L MacWilliam; C Fryer
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

5.  Shark cartilage-induced hepatitis.

Authors:  B Ashar; E Vargo
Journal:  Ann Intern Med       Date:  1996-11-01       Impact factor: 25.391

6.  Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition.

Authors:  Michael J Bonham; Anna Galkin; Bruce Montgomery; William L Stahl; David Agus; Peter S Nelson
Journal:  J Natl Cancer Inst       Date:  2002-11-06       Impact factor: 13.506

7.  Use of alternative medicine by women with early-stage breast cancer.

Authors:  H J Burstein; S Gelber; E Guadagnoli; J C Weeks
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

8.  Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions.

Authors:  H Boon; M Stewart; M A Kennard; R Gray; C Sawka; J B Brown; C McWilliam; A Gavin; R A Baron; D Aaron; T Haines-Kamka
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

9.  Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.

Authors:  M A Richardson; T Sanders; J L Palmer; A Greisinger; S E Singletary
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

10.  A clinical trial of amygdalin (Laetrile) in the treatment of human cancer.

Authors:  C G Moertel; T R Fleming; J Rubin; L K Kvols; G Sarna; R Koch; V E Currie; C W Young; S E Jones; J P Davignon
Journal:  N Engl J Med       Date:  1982-01-28       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.